title: Pancreatic cancer. Management.
abstract: Pancreatic cancer still represents a serious medical concern for which no adequate solution has thus far been found. Surgery is the only appropriate therapy, but has a survival rate of around 30-35% at three years, with an operative mortality below 3% and an operative morbidity approaching 10% of radically resected patients, all of which applies to surgery performed by expert teams in highly experienced sites.
authors.affiliation: Universidad Complutense, Hospital Universitario 12 de Octubre, Madrid, Spain. mhidalgo.hdoc@salud.madrid.org
authors.forename: M
authors.initials: M
authors.lastname: Hidalgo Pascual
authors.forename: E
authors.initials: E
authors.lastname: Ferrero Herrero
authors.forename: P
authors.initials: P
authors.lastname: Peláez Torres
authors.forename: Mj
authors.initials: M
authors.lastname: Castillo Fé
authors.forename: O
authors.initials: O
authors.lastname: Bonachia Naranjo
authors.forename: M
authors.initials: M
authors.lastname: Labalde Martínez
authors.forename: F
authors.initials: F
authors.lastname: Botella Ballesteros
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate